Rifampin

C. diff Risk

Low

Oral Bioavailability

Excellent

Approximate Cost

Spectrum Of Activity

General Information

Common Usage

  • Mycobacterial infections

  • Brucellosis

  • Osteomyelitis

  • Prosthetic joint infections due to Staphyloccocus aureus (always use in combination with other agents).

Drug Monitoring

Lab

  • Basline and periodic LFTs

Clinical

  • Multiple drug interactions

Adverse Effects

  • Nausea/vomiting, diarrhea

  • Abnormal liver enzymes

  • Rash (Steven-Johnson syndrome)

  • Myopathy

Major Interactions

Inducer of many CYP enzymes including 3A4, and 2C9.

Anticoagulants and anticonvulsants are among those affected but list of interacting drugs is large.

A Pharmacy consult is recommended when initiating rifampin therapy.

Pharmacology

Antimicrobial class: Antimycobacterial

Pregnancy category: C

Average serum half life: 3-4 hr

Biliary penetration: Therapeutic

CSF penetration: Therapeutic

Lung penetration: Therapeutic

Route of Elimination: Feces